MEDLINE Journals

    Topical corticosteroids as adjunctive therapy for bacterial keratitis.

    Authors

    Suwan-Apichon O, Reyes JM, Herretes S, et al. 

    Institution

    Faculty of Medicine, Khon Kaen University, Department of Ophthalmology, Khon Kaen, Thailand, 40000. osuwanapichon@hotmail.com

    Source

    Cochrane Database Syst Rev 2007; (4) :CD005430.

    Abstract

    BACKGROUND
    Bacterial keratitis is a serious ocular infectious disease that can lead to severe visual disability. Risk factors for bacterial corneal infection include contact lens wear, ocular surface disease, corneal trauma and previous ocular or eyelid surgery. Topical antibiotics constitute the mainstay of treatment in cases of bacterial keratitis where as the use of topical corticosteroids remains controversial. Topical corticosteroids are usually used to control inflammation using the smallest amount of the drug. Their use requires optimal timing, concomitant antibiotics and careful follow up.
    OBJECTIVES
    The objective of the review was to assess the clinical effectiveness and adverse effects of corticosteroids as adjunctive therapy for bacterial keratitis.
    SEARCH STRATEGY
    We searched CENTRAL, MEDLINE, EMBASE, and LILACS up to 15 January 2007. We also searched the Science Citation Index to identify additional studies that had cited the included trial, an online database of ongoing trials (www.clinicaltrials.gov), reference lists of included trials, earlier reviews and the American Academy of Ophthalmology guidelines. We also contacted experts to identify any unpublished and ongoing randomized trials.
    SELECTION CRITERIA
    We included randomized controlled trials evaluating adjunctive therapy with topical corticosteroids in people with bacterial keratitis.
    DATA COLLECTION AND ANALYSIS
    Two review authors independently screened all the retrieved articles. Methodological quality of the one included trial was assessed using forms developed using pre-specified criteria by at least two review authors. We planned to extract data on outcomes using forms developed for the purpose. We planned to report risk ratios for dichotomous outcomes and mean differences for continuous outcomes.
    MAIN RESULTS
    A single trial was eligible for inclusion in the review. Participants in the trial were randomized using a random numbers table. Allocation concealment was not attempted. Masking of participants, and care-providers was also not attempted. Outcome assessment was conducted independently by two physicians. Neither was masked to the treatment allocation. The trial reported the healing rate of epithelial defects and improvement in visual acuity.
    AUTHORS' CONCLUSIONS
    There are no good quality randomized trials evaluating the effects of adjunct use of topical corticosteroids in bacterial keratitis. The only randomized trial we identified in the literature suffered from major methodological inadequacies.

    Mesh

    Adrenal Cortex Hormones
    Chemotherapy, Adjuvant
    Eye Infections, Bacterial
    Humans
    Keratitis

    Language

    eng

    Pub Type(s)

    Journal Article Review

    PubMed ID

    17943856

    Content Manager
    Related Content

    Medical interventions for fungal keratitis.

    Therapeutic interventions for herpes simplex virus epithelial keratitis.

    Safety of topical corticosteroids in pregnancy.

    Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

    Glucocorticoid corticosteroids for Duchenne muscular dystrophy.

    Therapeutic drug monitoring of antiretrovirals for people with HIV.

    Topical anaesthesia alone versus topical anaesthesia with intracameral lidocaine for phacoemulsification.

    Systemic corticosteroids for acute gout.